FR2897060B1 - Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant - Google Patents

Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Info

Publication number
FR2897060B1
FR2897060B1 FR0601253A FR0601253A FR2897060B1 FR 2897060 B1 FR2897060 B1 FR 2897060B1 FR 0601253 A FR0601253 A FR 0601253A FR 0601253 A FR0601253 A FR 0601253A FR 2897060 B1 FR2897060 B1 FR 2897060B1
Authority
FR
France
Prior art keywords
same
preparing
pharmaceutical compositions
compositions containing
rimonabant monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0601253A
Other languages
English (en)
Other versions
FR2897060A1 (fr
Inventor
Gerard Coquerel
Helene Duplaa
Baptiste Fours
Olivier Monnier
Philippe Ochsenbein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2897060(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to FR0601253A priority Critical patent/FR2897060B1/fr
Priority to DO2007000023A priority patent/DOP2007000023A/es
Priority to EA200870236A priority patent/EA200870236A1/ru
Priority to ZA200806713A priority patent/ZA200806713B/xx
Priority to JP2008553793A priority patent/JP2009526025A/ja
Priority to AU2007213649A priority patent/AU2007213649A1/en
Priority to BRPI0707711-4A priority patent/BRPI0707711A2/pt
Priority to CA002641494A priority patent/CA2641494A1/fr
Priority to PCT/FR2007/000201 priority patent/WO2007090949A1/fr
Priority to KR1020087019391A priority patent/KR20080093042A/ko
Priority to CNA200780004742XA priority patent/CN101405271A/zh
Priority to EP07730917A priority patent/EP1984341A1/fr
Priority to ARP070100477A priority patent/AR059327A1/es
Priority to GT200700014A priority patent/GT200700014A/es
Priority to TW096104722A priority patent/TW200804343A/zh
Priority to UY30137A priority patent/UY30137A1/es
Publication of FR2897060A1 publication Critical patent/FR2897060A1/fr
Priority to IL192963A priority patent/IL192963A0/en
Publication of FR2897060B1 publication Critical patent/FR2897060B1/fr
Application granted granted Critical
Priority to US12/186,753 priority patent/US20090048449A1/en
Priority to NO20083521A priority patent/NO20083521L/no
Priority to MA31195A priority patent/MA30312B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0601253A 2006-02-08 2006-02-08 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant Expired - Fee Related FR2897060B1 (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR0601253A FR2897060B1 (fr) 2006-02-08 2006-02-08 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
DO2007000023A DOP2007000023A (es) 2006-02-08 2007-02-01 Monohidrato de rimonabant, su procedimiento de preparación y composiciones farmacéuticas que lo contienen.
CNA200780004742XA CN101405271A (zh) 2006-02-08 2007-02-05 利莫那班一水合物，它的制备方法与含有它的药物组合物
ZA200806713A ZA200806713B (en) 2006-02-08 2007-02-05 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
JP2008553793A JP2009526025A (ja) 2006-02-08 2007-02-05 リモナバント１水和物、これの調製方法およびこれを含む医薬組成物
AU2007213649A AU2007213649A1 (en) 2006-02-08 2007-02-05 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
BRPI0707711-4A BRPI0707711A2 (pt) 2006-02-08 2007-02-05 monohidrato de rimonabanto o respectivo processo de preparaÇço e as composiÇÕes farmacÊuticas que o contÊm
CA002641494A CA2641494A1 (fr) 2006-02-08 2007-02-05 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
PCT/FR2007/000201 WO2007090949A1 (fr) 2006-02-08 2007-02-05 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
KR1020087019391A KR20080093042A (ko) 2006-02-08 2007-02-05 리모나반트 모노히드레이트, 그의 제조 방법, 및 그를함유하는 제약 조성물
EA200870236A EA200870236A1 (ru) 2006-02-08 2007-02-05 Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
EP07730917A EP1984341A1 (fr) 2006-02-08 2007-02-05 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
GT200700014A GT200700014A (es) 2006-02-08 2007-02-06 Monohidrato de rimonabant, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen
ARP070100477A AR059327A1 (es) 2006-02-08 2007-02-06 Monohidrato de rimonabant su procedimiento de preparacion y composiciones farmaceuticas que lo contienen
TW096104722A TW200804343A (en) 2006-02-08 2007-02-08 Rimonabant monohydrate, its preparation method and the pharmaceutical compositions containing it
UY30137A UY30137A1 (es) 2006-02-08 2007-02-08 Monohidrato de rimonabant, su procedimiento de preparación y composiciones farmacéuticas que lo contienen
IL192963A IL192963A0 (en) 2006-02-08 2008-07-22 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
US12/186,753 US20090048449A1 (en) 2006-02-08 2008-08-06 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
NO20083521A NO20083521L (no) 2006-02-08 2008-08-13 Rimonabantmonohydrat, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende samme
MA31195A MA30312B1 (fr) 2006-02-08 2008-08-26 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0601253A FR2897060B1 (fr) 2006-02-08 2006-02-08 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Publications (2)

Publication Number Publication Date
FR2897060A1 FR2897060A1 (fr) 2007-08-10
FR2897060B1 true FR2897060B1 (fr) 2008-07-25

Family

ID=37075667

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0601253A Expired - Fee Related FR2897060B1 (fr) 2006-02-08 2006-02-08 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Country Status (20)

Country Link
US (1) US20090048449A1 (fr)
EP (1) EP1984341A1 (fr)
JP (1) JP2009526025A (fr)
KR (1) KR20080093042A (fr)
CN (1) CN101405271A (fr)
AR (1) AR059327A1 (fr)
AU (1) AU2007213649A1 (fr)
BR (1) BRPI0707711A2 (fr)
CA (1) CA2641494A1 (fr)
DO (1) DOP2007000023A (fr)
EA (1) EA200870236A1 (fr)
FR (1) FR2897060B1 (fr)
GT (1) GT200700014A (fr)
IL (1) IL192963A0 (fr)
MA (1) MA30312B1 (fr)
NO (1) NO20083521L (fr)
TW (1) TW200804343A (fr)
UY (1) UY30137A1 (fr)
WO (1) WO2007090949A1 (fr)
ZA (1) ZA200806713B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008026219A2 (fr) * 2006-09-01 2008-03-06 Hetero Drugs Limited Nouveaux polymorphes de rimonabant
WO2008056377A2 (fr) * 2006-11-06 2008-05-15 Cadila Healthcare Limited Nouvelles formes du rimonabant
PT3229799T (pt) * 2014-12-08 2019-01-29 Crystal Pharmatech Co Ltd Formas cristalinas de complexo supramolecular trissódico compreendendo valsartan e ahu-377 e métodos das mesmas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2831883B1 (fr) * 2001-11-08 2004-07-23 Sanofi Synthelabo Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
JP4746931B2 (ja) * 2005-07-22 2011-08-10 株式会社日立製作所 フラットディスプレイパネルモジュール及びフラットディスプレイ装置
WO2008026219A2 (fr) * 2006-09-01 2008-03-06 Hetero Drugs Limited Nouveaux polymorphes de rimonabant
WO2008035023A1 (fr) * 2006-09-19 2008-03-27 Cipla Limited Formes polymorphes de rimonabant

Also Published As

Publication number Publication date
EP1984341A1 (fr) 2008-10-29
JP2009526025A (ja) 2009-07-16
WO2007090949A1 (fr) 2007-08-16
KR20080093042A (ko) 2008-10-17
US20090048449A1 (en) 2009-02-19
ZA200806713B (en) 2009-10-28
BRPI0707711A2 (pt) 2011-05-10
AR059327A1 (es) 2008-03-26
FR2897060A1 (fr) 2007-08-10
MA30312B1 (fr) 2009-04-01
GT200700014A (es) 2007-09-19
IL192963A0 (en) 2009-02-11
UY30137A1 (es) 2007-09-28
AU2007213649A1 (en) 2007-08-16
TW200804343A (en) 2008-01-16
NO20083521L (no) 2008-10-24
EA200870236A1 (ru) 2009-02-27
CA2641494A1 (fr) 2007-08-16
DOP2007000023A (es) 2008-02-15
CN101405271A (zh) 2009-04-08

Similar Documents

Publication Publication Date Title
IL195748A0 (en) Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
FR2909379B1 (fr) Nouveaux derives heterocycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IL193467A0 (en) Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
HRP20130656T1 (hr) Derivati benzonitrila supstituirani glukopiranozilom, farmaceutski sastavi koji sadrže takve spojeve, njihova uporaba i postupak njihove proizvodnje
IL193385A0 (en) Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL206394A (en) Derivatives of 2-Benzylpyridine Filtration as Met Kinase Inhibitors, Process for their Preparation, Medication and Use
SI2036892T1 (sl) Derivati tetrahidro h benzazepinov postopek za njihovo pripravo in farmacevtski sestavkiki jih vsebujejo
PL2401263T3 (pl) Podstawione pochodne azotu, zawierająca pochodne kompozycja farmaceutyczna, i sposób leczenia choroby Parkinsona przy ich użyciu
FR2903404B1 (fr) Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL1707564T3 (pl) Pochodne indanylopiperazyn, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
EP2212325A4 (fr) Dérivé d' ester d'acide 2-arylméthylazetidine-carbapenem-3-carboxylique ou sels de ce dérivé, processus de préparation de ce composé et composition pharmaceutique le comprenant
ZA200803116B (en) Novel indole-containing beta agonists, method for producing them and their use as drugs
ZA200902414B (en) Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
ZA200804802B (en) Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
FR2897060B1 (fr) Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
ZA200904530B (en) Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
FR2940650B1 (fr) Nouveaux derives d'oxime du 3,5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant,et procede de preparation
ZA200902413B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
EP2222624A4 (fr) Dérivés de 4-nérolidylcatéchol, compositions pharmaceutiques comprenant ces dérivés et procédé de préparation de ceux-ci
SI1748043T1 (sl) Polisubstituirane spojine 1,1-piridiniloksiciklopropanaminov, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
ZA200807712B (en) Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
EP1994003A4 (fr) Dérivés de pipéridine, leur procédé de synthèse, leur emploi en tant qu'agents thérapeutiques et les compositions pharmaceutiques les incluant

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121031